Pharmafile Logo
Pharmafocus logo
Advanced Search

R&D

Showing 15 posts of 140 posts found.

Collaboration

The age of collaboration: why pharma companies now have to work together

December 9, 2015
Research and Development R&D, co-operation, collaboration, pharma

It seems 2015 may be remembered as the year of the mega merger; the year when all records were broken …

Feature
Lilly_labs_2

Lilly pulls plug on basal insulin Peglispro

December 8, 2015
Manufacturing and Production R&D, basal insulin peglispro, diabetes, lilly, peglispro, phase III failure

Lilly has decided to pull out of filing its diabetes drug basal insulin peglispro, after failing to convince regulators and …

News
anastrazole

Pharma company vows to plough profits back into R&D

November 30, 2015
Sales and Marketing Australia, R&D, breast cancer, profits, sales, social enterprise

An Australian pharma company has adopted a social enterprise model in order to be able to donate 100% of its …

News
Takeda oncology

Challenges in oncology R&D – part 2

November 25, 2015
Manufacturing and Production, Research and Development R&D, Takeda, oncology

Pharmafile put questions on the challenges pharma companies face when working in oncology R&D to Dixie-Lee Esseltine, vice president of …

Feature
clinical trials

Governments and industry ‘combining to stall drug development’

November 9, 2015
Research and Development, Sales and Marketing BMJ, R&D, drug development

Both government and industry practices are responsible for the innovation deficit in the pharmaceutical sector, meaning that “the majority of …

News
researchers examining test tube

Drugs later in development ‘winning the race to market’

November 4, 2015
Research and Development R&D, drug approval, drug development, market exclusivity

Nearly all later entrants to drug classes were in clinical testing or regulatory review before first-in-class approval, according to the …

News
Shire

Shire to acquire Dyax in $5.9 billion deal

November 2, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Dyax, M&A, MA, R&D, Shire, hereditary angioedema, rare disease

Shire has struck a deal to acquire the biotech firm Dyax for $5.9 billion, in order to acquire exclusive rights …

News
EU flag

European Commission funds €23m project to develop HIV vaccine

November 2, 2015
Research and Development, Sales and Marketing BioNTech, European Commission, HIV, R&D, horizon 2020

The European Commission has kicked-off a new €23 million research program to bring together researchers to work on a potential …

News
T-cell

$350m collaboration deal for BMS and Five Prime Therapeutics

October 15, 2015
Research and Development BMS, Bristol-Myers Squibb, R&D, five prime, immuno-oncology, tumours

Bristol-Myers Squibb has signed a collaboration agreement with the US biotech firm Five Prime Therapeutics, for a Colony Stimulating Factor …

News
MSD logo

Merck and Incyte to initiate Keytruda, epacadostat combo trial

October 15, 2015
Research and Development Incyte, Merck, R&D, melanoma, phase III, skin cancer

Merck and biopharma firm Incyte are to expand their clinical collaboration to include a Phase III study evaluating the combination …

News
boris_johnson_in_japan

Mayor of London announces Takeda, UCL R&D partnership

October 14, 2015
Research and Development London, R&D, Takeda, UCL, neurology

Takeda is teaming up with researchers at University College London (UCL) to identify and validate novel target genes for the …

News
Teva image

Teva joins Watson Health in R&D link-up

October 14, 2015
Research and Development Big Data, R&D, Teva, Watson Health, ibm

Teva has partnered with the IBM Watson Health Cloud to create a global technology platform to aid its R&D efforts …

News

Pharma ‘is getting better at drug R&D’

September 23, 2015
Research and Development R&D, drug development, market access, productivity

An investigation into pharma R&D data shows that drugmakers are becoming more successful at identifying the right candidates for drug …

News
lab sign

Medimmune and Cancer Research UK launch new drug discovery lab

September 11, 2015
Research and Development AstraZeneca, Cambridge, Cancer, Cancer Research UK, MedImmune, R&D, george freeman

MedImmune and the UK’s biggest cancer charity have opened a new laboratory for joint cancer research.Research at the laboratory, which …

News
Westminster

Pharma leaders urge UK Government not to cut spending

September 9, 2015
Research and Development Autumn spending review, George Osborne, R&D, government, research, research and development, research funding

Representatives of more than 200 life sciences organisations have urged the UK government to protect the sector from spending cuts. …

News

Latest content

GSK shares data from global shingles survey

December 1, 2023

AbbVie to acquire ImmunoGen for approximately $10.1bn

December 1, 2023

FDA accepts NDA for Karuna’s schizophrenia treatment

November 30, 2023

Vivos Therapeutics gains FDA 510(k) clearance for sleep apnea treatment device

November 30, 2023

Tolremo doses first patient in phase 1 trial for drug to combat transcriptional cancer drug resistance

November 29, 2023